# Single or Combined Protocols for NV-AMD

> **NCT03552770** · PHASE4 · COMPLETED · sponsor: **University Hospital of Ferrara** · enrollment: 109 (actual)

## Conditions studied

- Age-Related Macular Degeneration

## Interventions

- **DRUG:** Bevacizumab

## Key facts

- **NCT ID:** NCT03552770
- **Lead sponsor:** University Hospital of Ferrara
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-11-23
- **Primary completion:** 2016-11-24
- **Final completion:** 2016-12-29
- **Target enrollment:** 109 (ACTUAL)
- **Last updated:** 2018-06-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03552770

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03552770, "Single or Combined Protocols for NV-AMD". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03552770. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*